Allspring Global Investments
RLAY icon

Allspring Global Investments’s Relay Therapeutics RLAY Stock Holding History

Allspring Global Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
66,123
-6,616
-9% -$96K ﹤0.01% 1190
2026
Q1 		$783K Buy
72,739
+7,292
+11% +$65.2K ﹤0.01% 1251
2025
Q4 		$535K Buy
65,447
+5,704
+10% +$40.7K ﹤0.01% 1354
2025
Q3 		$318K Sell
59,743
-588
-1% -$2.24K ﹤0.01% 1466
2025
Q2 		$212K Sell
60,331
-3,275
-5% -$9.74K ﹤0.01% 1539
2025
Q1 		$157K Buy
63,606
+22,307
+54% +$87.4K ﹤0.01% 1672
2024
Q4 		$170K Buy
41,299
+96
+0.2% +$522 ﹤0.01% 1688
2024
Q3 		$292K Buy
41,203
+2,547
+7% +$19K ﹤0.01% 1604
2024
Q2 		$252K Buy
38,656
+29,087
+304% +$199K ﹤0.01% 1661
2024
Q1 		$79.4K Buy
+9,569
New +$93.3K ﹤0.01% 1883
2023
Q1 		– Sell
-1,113
Closed -$16.6K – 2913
2022
Q4 		$16.6K Sell
1,113
-25
-2% -$479 ﹤0.01% 2624
2022
Q3 		$25K Hold
1,138
– – ﹤0.01% 2571
2022
Q2 		$19K Sell
1,138
-19,746
-95% -$423K ﹤0.01% 2500
2022
Q1 		$625K Buy
20,884
+1,896
+10% +$46K ﹤0.01% 2127
2021
Q4 		$583K Buy
+18,988
New +$600K ﹤0.01% 2233

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Allspring Global Investments's RLAY Position: Q2 2026 in Review

Allspring Global Investments reduced its Relay Therapeutics (RLAY) stake by 9.1% in Q2 2026, selling an estimated $96K and leaving 66,123 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Allspring Global Investments first reported a position in RLAY in Q4 2021 and has held it in 15 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Allspring Global Investments held 66,123 shares of Relay Therapeutics worth $1.17M as of Q2 2026.
  • Allspring Global Investments sold 6,616 Relay Therapeutics shares in Q2 2026, an estimated $96K.
  • Relay Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1190 holding.
  • Allspring Global Investments first reported a position in Relay Therapeutics in Q4 2021 and has held it in 15 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.